Candidemia (Sub-Category)

Candidemia Education Module

Dr. Andrew Morris, MD MS FRCPC

Developed by:  Dr. Andrew M. Morris, MD MS FRCPC with contributions from the CAHO ASP Project Team


  • Many patients in the intensive care unit are at risk for candidemia.
  • Attempts to predict who might develop candidemia suffer from lack of specificity.
  • Empiric antifungal therapy for critically ill patients is not beneficial.
  • Candida rarely causes pneumonia in critically ill patients.
  • There is no high-quality evidence demonstrating that one antifungal or class of antifungals is better than another.  Fluconazole and echinocandins are better tolerated that amphotericin B.
  • C. albicans is the most common candidal isolate and can be reliably treated with fluconazole.

Full PDF article:

Council of Academic Hospitals of Ontario (CAHO) Antimicrobial Stewardship in the Intensive Care Unit ARTIC Project: Candidemia Education Module